Shirkey H. Therapeutic orphans. J Pediatr 1968; 72(1): 119-20.
Frattarelli DA, Galinkin JL, Green TP, et al. Off-label use of drugs in children. Pediatrics 2014; 133(3): 563-7.
Meadows WA, Hollowell BD. ‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use. Int J Impot Res 2008; 20(2): 135-44.
Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316(7128): 343-5.
O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110(5): e52.
McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000; 83(6): 498-501.
Jong GW, Eland IA, Sturkenboom MC, et al. Determinants for drug prescribing to children below the minimum licensed age. Eur J Clin Pharmacol 2003; 58(10): 701-5.
Thompson DF, Heflin NR. Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am J Hosp Pharm 1987; 44(4): 792-4.
Carvalho PR, Carvalho CG, Alievi PT, et al. Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit. J Pediatr (Rio J) 2003; 79(5): 397-402.
Carvalho CG, Ribeiro MR, Bonilha MM, et al. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores. J Pediatr (Rio J) 2012; 88(6): 465-70.
Dos Santos L, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: Off-label, unlicensed and high-alert medications. Farm Hosp 2012; 36(4): 180-6.
Costa PQ, Rey LC, Coelho HL. Lack of drug preparations for use in children in Brazil. J Pediatr (Rio J) 2009; 85(3): 229-35.
Dell’Aera M, Gasbarro AR, Padovano M, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007; 29(4): 361-7.
Rocchi F, Paolucci P, Ceci A, et al. The European paediatric legislation: Benefits and perspectives. Ital J Pediatr 2010; 36: 56.
Lindell-Osuagwu L, Hakkarainen M, Sepponen K, et al. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation. J Clin Pharm Ther 2014; 39(2): 144-53.
Marchetti F, Bua J, Ventura A, et al. The awareness among paediatricians of off-label prescribing in children: A survey of Italian hospitals. Eur J Clin Pharmacol 2007; 63(1): 81-5.
Ceci A, Felisi M, Baiardi P, et al. Medicines for children licensed by the European Medicines Agency (EMEA): The balance after 10 years. Eur J Clin Pharmacol 2006; 62(11): 947-52.
’t Jong GW, Vulto AG, de Hoog M, et al. Unapproved and off-label use of drugs in a children’s hospital. N Engl J Med 2000; 343(15): 1125.
Doherty DR, Pascuet E, Ni A, et al. Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies. Can J Anaesth 2010; 57(12): 1078-88.
Ferreira LeA, Ibiapina CaC, Machado MG, et al. High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit. Rev Assoc Med Bras 2012; 58(1): 82-7.
Khdour MR, Hallak HO, Alayasa KS, et al. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm 2011; 33(4): 650-5.
Tramontina MY, Heineck I, Dos Santos L. Use of non-formulary drugs in children at a Brazilian teaching hospital: A descriptive study. Pharm Pract (Granada) 2013; 11(1): 17-23.